[13C8]-Vipivotide tetraxetan
| Catalog Number |
ACMA00065186 |
| Description |
Vipivotide tetraxetan is intended for Pharmaceuticals applications and is used for the treatment of prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC). All information about [13C8]-Vipivotide tetraxetan is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. |
| Molecular Weight |
1050.1 |
| Molecular Formula |
C4113C8H71N9O16 |
| Purity |
≥98% |
| Isotopic Enrichment |
99% 13C |
| Stability |
≥1 year |
| Unlabeled CAS |
1702967-37-0 |
Please kindly note that our products and services are for research use only.
